Observational analysis reveals 47% of high prescribers continued BSHO usage, suggesting potential issues with antibiotic stewardship.
Among 70 hospitalists across three facilities, 47% of high prescribers of broad-spectrum hospital-onset (BSHO) agents remained high in the subsequent period versus 24% for initially high prescribers of anti-MRSA agents. Findings of persistence of high prescribing add credibility to our metric for BSHO agents but not anti-MRSA agents.
No takes yet. Share an insight, caveat, or question.
Prakash-Asrani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: